Medlis Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.20 M
as on 20-12-2024
- Paid Up Capital ₹ 2.20 M
as on 20-12-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.40 M
as on 20-12-2024
- Revenue -79.55%
(FY 2022)
- Profit -91.88%
(FY 2022)
- Ebitda -52.35%
(FY 2022)
- Net Worth 3.23%
(FY 2022)
- Total Assets 26.73%
(FY 2022)
About Medlis Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.20 M and a paid-up capital of Rs 2.20 M.
The company currently has active open charges totaling ₹9.40 M.
Meenakshi Kulshrestha and Sunil Kulshrestha serve as directors at the Company.
- CIN/LLPIN
U85100DL2013PTC256627
- Company No.
256627
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Medlis Healthcare Private Limited offer?
Medlis Healthcare Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Medical Tubes, Diagnostic Medical Imaging Equipment, Ultrasound Accessories, Surgical & ICU Equipments, Oxygen Flow Meter, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant, Pulse Oximeter, Glucometer & POCT Devices, Thermometers & Flowmeters.
Who are the key members and board of directors at Medlis Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Kulshrestha  | Director | 16-Aug-2013 | Current |
| Meenakshi Kulshrestha | Director | 16-Aug-2013 | Current |
Financial Performance of Medlis Healthcare.
Medlis Healthcare Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 79.55% decrease. The company also saw a substantial fall in profitability, with a 91.88% decrease in profit. The company's net worth moved up by a moderate rise of 3.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medlis Healthcare?
In 2021, Medlis Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Dec 2021 | ₹0.60 M | Open |
Others Creation Date: 15 Feb 2017 | ₹8.80 M | Open |
How Many Employees Work at Medlis Healthcare?
Unlock and access historical data on people associated with Medlis Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medlis Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medlis Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
